The insider sales are routine and non-informative given the trivial dollar amount and pattern of exercise-and-sell. No bearish read-through. Monitor upcoming clinical trial readouts for MLYS's pipeline as the primary catalyst.
How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Jun 18 $24.63entry
- T+1 · 5mo ago +3.00%α +3.32% · $25.37
- T+5 · 5mo ago +6.94%α +8.61% · $26.34
- T+20 · 4mo ago +9.95%α +9.41% · $27.08
- T+60 · 2mo ago +17.54%α +15.65% · $28.95
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Two insiders at Mineralys Therapeutics (MLYS) sold a combined $310K in open-market transactions over a 7-day window. The dollar amount is trivial relative to the $2.0B market cap (0.0155%), and the sales follow option exercises, indicating routine tax/vesting-related liquidity rather than a bearish signal.
Key Financial Metrics
Key Facts
- CMO Rodman David Malcom sold 9,900 shares at $23.81 on June 15, 2026, for $235K
- Director Daphne Karydas sold 3,000 shares at $25.00 on June 17, 2026, for $75K
- Total open-market sales of $310K represent 0.0155% of MLYS's $2.0B market cap
- Both sales were preceded by option exercises at nominal or low strike prices, consistent with tax withholding or diversification
Financial Impact
Total insider sales of $310K are immaterial at 0.0155% of market cap; no financial impact on the company.
Risk Factors
- No material risk identified from this cluster; the sales are liquidity-driven and not indicative of fundamental deterioration
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-MLYS-1781745507906 |
Track record
35 reports on MLYS
4 of 7 bullish or bearish reports moved the stock their way by T+20. Best: +20.97% at T+20 after the Jun 11, 2026 report. 5 of 10 went positive at some point.
Filters
- Nov 8, 20268d ago Press Release Bullish 6/10 Entry $15.81 Now $14.53 −8.10% settles Dec 8
- Nov 4, 202612d ago 8-K Neutral 4/10 Entry $15.24 Now $14.53 −4.66% settles Dec 4
- Nov 3, 202613d ago Institutional Cluster Neutral 2/10 Entry $15.99 Now $14.53 −9.13% settles Dec 2
- Oct 29, 202618d ago 8-K Bullish 6/10 Entry $18.18 Now $14.53 −20.08% settles Nov 30
- Oct 28, 202619d ago Press Release Bullish 6/10 Entry $21.38 Now $14.53 −32.04% settles Nov 25
- Oct 20, 202627d ago 3 Neutral 2/10 Entry $21.10 Now $14.53 −31.14% settles Nov 18
- Oct 20, 202627d ago 3 Neutral 2/10 Entry $21.10 Now $14.53 −31.14% settles Nov 18
- Oct 19, 202628d ago 8-K Neutral 2/10 Entry $21.58 Now $14.53 −32.67% settles Nov 17
- Oct 13, 20264w ago 144 Neutral 3/10 Entry $20.76 to $16.16 Now $14.53 −30.01% ▼ −22.16% −20.89% vs SPY
- Sep 30, 20266w ago 144 Neutral 3/10 Entry $23.72 to $21.24 Now $14.53 −38.74% ▼ −10.46% −11.16% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers